Additional file 7 of Bone marrow infiltrated natural killer cells predicted the anti-leukemia activity of MCL1 or BCL2 inhibitors in acute myeloid leukemia
We report that BRD9/7 inhibition alters multiple biological pathways in uterine leiomyosarcoma cells Examine the transcriptome alteration in uterine leiomyosarcoma cells with or without BRD9/7 inhibit
This study used microarray expression analysis to identify global changes in transcript alteration in response to MEK inhibition. Genes under ERK control were identified in a panel of V600E BRAF and R
Pazopanib is an FDA approved Vascular Endothelial Growth Factor Receptor inhibitor. We previously reported that it also inhibits tumor cell B-Raf activity in an experimental brain metastatic setting.
